SCHEMBL27328243

SCHEMBL27328243

CC(C)[C@@H]1CNCCCO1

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 8/20 0.32
SLC6A4 P31645 8/20 0.32
SLC6A3 Q01959 6/20 0.32
MLNR O43193 1/20 0.30
ADRB2 P07550 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30
HTR2C P28335 1/20 0.30
OPRK1 P41145 1/20 0.30
KCNH2 Q12809 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
MAPK1 P28482 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25146904 1.00 SLC6A2 (0.32) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL12206943 0.86
SCHEMBL12206944 0.86
Fluoride SCHEMBL28166838 0.86 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL516648 0.86
Bromide SCHEMBL2813842 0.84 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3MLNRADRB2
Hydrochloric Acid SCHEMBL9054370 0.84 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3MLNRADRB2
Hydrochloric Acid SCHEMBL17376453 0.84 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL27944937 0.79 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL14118827 0.74 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3MLNRADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129881-A1 COMPOUNDS, COMPOSITIONS, AND MEZHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING WAVEBREAK THERAPEUTICS LIMITED (US) 2024-06-20 WO disclosed